Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
BJU International
|
August 27, 2004
The prevalence and nature of orgasmic dysfunction after radical prostatectomy
Jennifer L Barnas, Steven Pierpaoli, Patricia Ladd, et al.
Plos One
|
September 22, 2011
Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis
Richard B Bankert, Sathy V Balu-Iyer, Kunle Odunsi, et al.
Frontiers in Immunology
|
January 27, 2025
Interferon activation in bone marrow long-lived plasma cells in systemic lupus erythematosus
Diana F Alzamareh, Nida Meednu, Neha Nandedkar-Kulkarni, et al.
Journal of Autoimmunity
|
May 16, 2019
Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN
Yannick Dieudonné, Vincent Gies, Aurélien Guffroy, et al.
Cancer Immunity
|
July 25, 2013
Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells
Michelle R Simpson-Abelson, Jenni L Loyall, Heather K Lehman, et al.
Arthritis Care & Research
|
April 28, 2026
Clinical, histological, and serological predictors of renal function loss in lupus nephritis
Shangzhu Zhang, Laurence Magder, Daniel Goldman, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response
Rufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)
|
March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network
Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research
|
October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Andrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
BJU International
|
August 27, 2004
The prevalence and nature of orgasmic dysfunction after radical prostatectomy
Jennifer L Barnas, Steven Pierpaoli, Patricia Ladd, et al.
Plos One
|
September 22, 2011
Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis
Richard B Bankert, Sathy V Balu-Iyer, Kunle Odunsi, et al.
Frontiers in Immunology
|
January 27, 2025
Interferon activation in bone marrow long-lived plasma cells in systemic lupus erythematosus
Diana F Alzamareh, Nida Meednu, Neha Nandedkar-Kulkarni, et al.
Journal of Autoimmunity
|
May 16, 2019
Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN
Yannick Dieudonné, Vincent Gies, Aurélien Guffroy, et al.
Cancer Immunity
|
July 25, 2013
Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells
Michelle R Simpson-Abelson, Jenni L Loyall, Heather K Lehman, et al.
Arthritis Care & Research
|
April 28, 2026
Clinical, histological, and serological predictors of renal function loss in lupus nephritis
Shangzhu Zhang, Laurence Magder, Daniel Goldman, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response
Rufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)
|
March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network
Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research
|
October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Andrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Page
of 3